ATE517875T1 - 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminochinazolinderivat - Google Patents

4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminochinazolinderivat

Info

Publication number
ATE517875T1
ATE517875T1 AT07714569T AT07714569T ATE517875T1 AT E517875 T1 ATE517875 T1 AT E517875T1 AT 07714569 T AT07714569 T AT 07714569T AT 07714569 T AT07714569 T AT 07714569T AT E517875 T1 ATE517875 T1 AT E517875T1
Authority
AT
Austria
Prior art keywords
methylaminochinazoline
benzoylaminophenyl
dimethoxy
derivative
optionally substituted
Prior art date
Application number
AT07714569T
Other languages
English (en)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Priority claimed from PCT/JP2007/053066 external-priority patent/WO2007097317A1/ja
Application granted granted Critical
Publication of ATE517875T1 publication Critical patent/ATE517875T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07714569T 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminochinazolinderivat ATE517875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
PCT/JP2007/053066 WO2007097317A1 (ja) 2006-02-21 2007-02-20 ４－（３－ベンゾイルアミノフェニル）－６，７－ジメトキシ－２－メチルアミノキナゾリン誘導体

Publications (1)

Publication Number Publication Date
ATE517875T1 true ATE517875T1 (de) 2011-08-15

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07714569T ATE517875T1 (de) 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminochinazolinderivat

Country Status (17)

Country Link
JP (1) JP4778550B2 (de)
KR (1) KR101278852B1 (de)
AT (1) ATE517875T1 (de)
BR (1) BRPI0708098B8 (de)
CY (1) CY1112554T1 (de)
DK (1) DK1992622T3 (de)
ES (1) ES2368089T3 (de)
HR (1) HRP20110604T1 (de)
IL (1) IL193322A (de)
JO (1) JO2726B1 (de)
MY (1) MY146275A (de)
NZ (1) NZ569936A (de)
PT (1) PT1992622E (de)
RS (1) RS51969B (de)
RU (1) RU2431632C2 (de)
SI (1) SI1992622T1 (de)
TW (1) TWI404709B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123641A4 (de) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Kristall, amorphe form und salt von methyl n-[3-(6,7-dimethoxy- 2-methylaminochinazolin-4-yl)phenyl]terephthalamsäure
JP5060561B2 (ja) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規外用剤
WO2009025238A1 (ja) 2007-08-17 2009-02-26 Eisai R & D Management Co., Ltd. キナゾリン誘導体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661533B2 (en) * 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
DE69819349T2 (de) * 1997-08-29 2004-07-22 Tularik Ltd. 1-amino-7-isochinolin-derivate als serin protease inhibitoren
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
CN1934100A (zh) * 2004-03-23 2007-03-21 万有制药株式会社 取代喹唑啉或吡啶并嘧啶衍生物

Also Published As

Publication number Publication date
DK1992622T3 (da) 2011-09-05
JO2726B1 (en) 2013-09-15
IL193322A (en) 2014-04-30
KR101278852B1 (ko) 2013-07-01
HRP20110604T1 (hr) 2011-09-30
BRPI0708098B8 (pt) 2021-05-25
NZ569936A (en) 2010-07-30
PT1992622E (pt) 2011-09-19
SI1992622T1 (sl) 2011-11-30
RU2431632C2 (ru) 2011-10-20
JP4778550B2 (ja) 2011-09-21
TWI404709B (zh) 2013-08-11
BRPI0708098A2 (pt) 2011-05-17
IL193322A0 (en) 2009-05-04
HK1122025A1 (en) 2009-05-08
CY1112554T1 (el) 2016-02-10
RU2008137654A (ru) 2010-03-27
KR20080094811A (ko) 2008-10-24
MY146275A (en) 2012-07-31
RS51969B (sr) 2012-02-29
BRPI0708098B1 (pt) 2019-08-06
TW200812980A (en) 2008-03-16
JPWO2007097317A1 (ja) 2009-07-16
ES2368089T3 (es) 2011-11-14

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
MY150989A (en) Benzothiazole compounds useful for raf inhibition
HRP20120323T1 (en) Diarylhydantoin compounds
CY1111671T1 (el) Ετεροκυκλικη ενωση
MY158982A (en) Heterocyclic compound
WO2009028629A1 (ja) 複素環化合物およびその用途
PH12013501873A1 (en) Novel imidazo-oxazine compound or salt thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
WO2008110355A8 (en) Quinoline derivatives as fungicides
WO2008019395A3 (en) Compounds for improving learning and memory
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
AU2012310674B2 (en) Radioactive fluorine labeled compound
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
PH12015501146A1 (en) Hydantoin derivative
EA201071424A1 (ru) Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
WO2006078984A3 (en) Uses of methylphenidate derivatives
MY158199A (en) Substituted pyridine compound
WO2009111028A8 (en) Aurora kinase inhibitors
MX2010013184A (es) Compuesto heterocíclico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1992622

Country of ref document: EP